logo
"Hug Your Homies": The Story Behind a Little Sticker With a Big Goal

"Hug Your Homies": The Story Behind a Little Sticker With a Big Goal

Yahoo2 days ago

'Hug your homies and tell them you love them.'It's a straightforward suggestion. You may have seen it in the form of green, rectangular stickers on ski helmets or elsewhere, particularly if your home mountain is Alta Ski Area, Utah. The phrase and sticker was popularized by Dan Parisi, 29, who moved to Salt Lake City about five years ago, fell in love with the skiing, and stayed put. He was inspired to honor a member of the Alta community who died by suicide in December 2023. The stickers served as what Parisi called 'a subtle reminder to check in on your friends' and 'hold your loved ones tight.'The stickers proved popular. Parisi handed them out that winter, and when he ran dry, people began asking where they could get more. Then, as the season wound down, one of his friends suggested during a chairlift ride that he take the stickers' concept further and start creating apparel. Parisi, who's faced his own challenges with mental health, took the idea seriously—and started shaping it into what would become Hug Your Homies.Want to keep up with the best stories and photos in skiing? Subscribe to the new Powder To The People newsletter for weekly updates.
Hug Your Homies is now more than just a sticker—it's a fledgling brand with a varied lineup of apparel that donates a portion of its proceeds to two organizations Parisi views highly, one local and one national: Alta Community Enrichment (ACE) and the American Foundation for Suicide Prevention (AFSP).Hug Your Homies arrives at a time when skiers—and the mountain community at large—seem more open to conversations about mental health than ever. Skier and advocate John Padilla has now created three films under the Mountain in My Mind banner, each espousing a mix of gnarly shredding and frank conversations about suicide, depression, and anxiety. Professional skier Drew Petersen's short documentary, Ups and Downs, which followed his battle with PTSD, bipolar disorder, and a traumatic brain injury, released online to wide acclaim in 2022.
Hug Your Homies, then, fits into a wider ski culture shift, but it has its own quirky flavor. One of the brand's shirts reads 'Kiss your homies with your eyes open' and, on Parisi's website, is accompanied by a brief description that includes the sentence, '​​You give each other a quick lil smooch because they're your dawg.' To an older audience, that line might seem bizarre. But for a younger generation raised at the intersection of irony and sincerity, it's both funny and heartfelt. Parisi, through his less over-the-top stickers, aimed to create something that felt natural, mining a vein that already existed in the ski community: mutual adoration of the people we spend time in the mountains with. He said he chose the catchphrase 'hug your homies' because it's 'something that you can hear a skier saying.''I feel like it's such a strong message that can be applied to so many things, which is what I love,' Parisi added.Parisi wants Hug Your Homies to do more than create conversations about mental health and make merch. One day, he hopes that the brand will have its own gathering space and community hub, but activities like group hikes and mini ramp sessions, which provide an alternative to the partying popular in mountain towns, are more tangible.
He's already gotten started. In early June, Parisi hosted a small rail jam at the base of Alta Ski Area with the help of his friends, setting up a series of PVC tubes so people could hang out and work on their tricks. And, this summer, he has numerous pop-ups planned at Park Silly, an open-air market in Park City, Utah.
Beyond that, Parisi is still figuring out the details of what might come next, and admits, with a laugh, that 'I'm not the best event planner.' In the meantime, though, his goals, like his stickers, aren't too complicated.'I try to just be a friendly face in the community,' he said. 'I try to brighten people's days as much as I can.'
"Hug Your Homies": The Story Behind a Little Sticker With a Big Goal first appeared on Powder on Jun 10, 2025

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

"Hug Your Homies": The Story Behind a Little Sticker With a Big Goal
"Hug Your Homies": The Story Behind a Little Sticker With a Big Goal

Yahoo

time2 days ago

  • Yahoo

"Hug Your Homies": The Story Behind a Little Sticker With a Big Goal

'Hug your homies and tell them you love them.'It's a straightforward suggestion. You may have seen it in the form of green, rectangular stickers on ski helmets or elsewhere, particularly if your home mountain is Alta Ski Area, Utah. The phrase and sticker was popularized by Dan Parisi, 29, who moved to Salt Lake City about five years ago, fell in love with the skiing, and stayed put. He was inspired to honor a member of the Alta community who died by suicide in December 2023. The stickers served as what Parisi called 'a subtle reminder to check in on your friends' and 'hold your loved ones tight.'The stickers proved popular. Parisi handed them out that winter, and when he ran dry, people began asking where they could get more. Then, as the season wound down, one of his friends suggested during a chairlift ride that he take the stickers' concept further and start creating apparel. Parisi, who's faced his own challenges with mental health, took the idea seriously—and started shaping it into what would become Hug Your to keep up with the best stories and photos in skiing? Subscribe to the new Powder To The People newsletter for weekly updates. Hug Your Homies is now more than just a sticker—it's a fledgling brand with a varied lineup of apparel that donates a portion of its proceeds to two organizations Parisi views highly, one local and one national: Alta Community Enrichment (ACE) and the American Foundation for Suicide Prevention (AFSP).Hug Your Homies arrives at a time when skiers—and the mountain community at large—seem more open to conversations about mental health than ever. Skier and advocate John Padilla has now created three films under the Mountain in My Mind banner, each espousing a mix of gnarly shredding and frank conversations about suicide, depression, and anxiety. Professional skier Drew Petersen's short documentary, Ups and Downs, which followed his battle with PTSD, bipolar disorder, and a traumatic brain injury, released online to wide acclaim in 2022. Hug Your Homies, then, fits into a wider ski culture shift, but it has its own quirky flavor. One of the brand's shirts reads 'Kiss your homies with your eyes open' and, on Parisi's website, is accompanied by a brief description that includes the sentence, '​​You give each other a quick lil smooch because they're your dawg.' To an older audience, that line might seem bizarre. But for a younger generation raised at the intersection of irony and sincerity, it's both funny and heartfelt. Parisi, through his less over-the-top stickers, aimed to create something that felt natural, mining a vein that already existed in the ski community: mutual adoration of the people we spend time in the mountains with. He said he chose the catchphrase 'hug your homies' because it's 'something that you can hear a skier saying.''I feel like it's such a strong message that can be applied to so many things, which is what I love,' Parisi wants Hug Your Homies to do more than create conversations about mental health and make merch. One day, he hopes that the brand will have its own gathering space and community hub, but activities like group hikes and mini ramp sessions, which provide an alternative to the partying popular in mountain towns, are more tangible. He's already gotten started. In early June, Parisi hosted a small rail jam at the base of Alta Ski Area with the help of his friends, setting up a series of PVC tubes so people could hang out and work on their tricks. And, this summer, he has numerous pop-ups planned at Park Silly, an open-air market in Park City, Utah. Beyond that, Parisi is still figuring out the details of what might come next, and admits, with a laugh, that 'I'm not the best event planner.' In the meantime, though, his goals, like his stickers, aren't too complicated.'I try to just be a friendly face in the community,' he said. 'I try to brighten people's days as much as I can.' "Hug Your Homies": The Story Behind a Little Sticker With a Big Goal first appeared on Powder on Jun 10, 2025

Sam's Club says it plans to remove synthetic dyes from private brand by end of 2025
Sam's Club says it plans to remove synthetic dyes from private brand by end of 2025

Yahoo

time05-06-2025

  • Yahoo

Sam's Club says it plans to remove synthetic dyes from private brand by end of 2025

BENTONVILLE, Ark. (KNWA/KFTA) — Sam's Club announced on Thursday plans to eliminate more than 40 ingredients from its private label brand, Member's Mark, by the end of the year. The wholesale chain said in a news release that under the initiative, 'Made Without,' it will alter its food and beverage products to offer items without certain ingredients in order to cater to specific dietary preferences. In April, U.S. Health Secretary Robert F. Kennedy Jr. and Food and Drug Administration Commissioner Marty Makary announced plans to phase out several types of artificial, petroleum-based dyes used as food coloring in various snacks, drinks and desserts that line grocery shelves, mainly citing kids' health as the reason for the move. 'We take pride in the high-quality ingredients that go into our products, but what truly differentiates us are the ingredients we consciously leave out,' Julie Barber, chief merchant at Sam's Club, said. 'Our 'Made Without' commitment underscores our aspiration to be members' go-to destination for quality at a disruptive value. For us, it's about listening to our members and providing the items that resonate with their lifestyles.' Here is the list of ingredients Sam's Club plans to eliminate from its 'Made Without' products: Acesulfame-K (Acesulfame Potassium) (Ace-K) Acetylated Ester of Mono & Diglycerides (ACETEM) Artificial Flavors Aspartame Azodicarbonamide (ADA) Benzyl Alcohol Butylated hydroxy anisole (BHA) Butylated Hydroxytoluene (BHT) Butylparaben Certified Synthetic Colors/FD&C Colors Cocamide DEA Cyclamates Cyclopentasiloxane Cyclotetrasiloxane Dioctyl Sodium Sulfosuccinate (DSS) DMDM Hydantoin Ethyl Vanillin Formaldehyde Hexa, Hepta, Octa Esters of Sucrose High Fructose Corn Syrup Lactylated Esters of Mono & Diglycerides (OLEON) Methylparaben Neotame Phthalates Potassium Bisulfate Potassium Bisulfite Potassium Nitrate/Nitrite Propyl Gallate Propylparaben Saccharin (All) Simplesse Sodium Ferrocyanide Sodium Propionate Sucroglycerides Sucrose Polyester Talc Tertiary Butylhydroquinone (Except for our 35-pound food service frying oils) Toluene Sam's Club said it has already released cookies and other snacks without artificial colors. The retailer is also offering fresh sushi as part of its 'Made Without' program. In addition to Sam's Club, Tyson recently announced it planned to eliminate synthetic dyes from its products, according to CEO Donnie King. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Acerand Therapeutics Initiates First-in-Human Phase I Clinical Trial of ACE-232, a Novel CYP11A1 Inhibitor for Advanced Prostate Cancer
Acerand Therapeutics Initiates First-in-Human Phase I Clinical Trial of ACE-232, a Novel CYP11A1 Inhibitor for Advanced Prostate Cancer

Yahoo

time05-06-2025

  • Yahoo

Acerand Therapeutics Initiates First-in-Human Phase I Clinical Trial of ACE-232, a Novel CYP11A1 Inhibitor for Advanced Prostate Cancer

SHANGHAI & INDIANAPOLIS, June 05, 2025--(BUSINESS WIRE)--Acerand Therapeutics, a clinical-stage biotech company focusing on the discovery and development of innovative small-molecule therapies in oncology, today announced the dosing of the first patient in its first-in-human Phase I clinical trial (NCT06801236) of ACE-232, a novel oral inhibitor of CYP11A1. The trial is being conducted in patients with metastatic castration-resistant prostate cancer (mCRPC). This multicenter Phase I study is being conducted in both the United States and China. The study comprises two parts: a dose-escalation phase (Phase IA) and a dose-optimization phase (Phase IB). The primary objectives are to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), as well as preliminary clinical activity of ACE-232, and to determine the recommended Phase II dose (RP2D). Professor Emmanuel Antonarakis, Director of Genitourinary Oncology at Masonic Cancer Center, University of Minnesota, is serving as the global coordinating Principal Investigator for the study. "I would like to congratulate the Acerand team, the research staff, and the first patient for helping us to reach this important milestone," says Dr. Antonarakis. Preclinical data demonstrated that ACE-232 possesses superior potency, efficacy, and pharmacokinetic properties (flat PK curve and long half-life profile) compared to other investigational CYP11A1 inhibitors, including MK-5684 (Opevesostat, formerly known as ODM-208). ACE-232 showed excellent tolerability in preclinical models, presenting a wide therapeutic window for clinical development. The initiation of this trial marks a significant milestone for Acerand, representing its first clinical study in the United States and highlighting its strategic commitment to the global development of innovative cancer therapies that address major unmet medical needs. About ACE-232 ACE-232 is a highly potent and selective small-molecule inhibitor of CYP11A1, a key adrenal enzyme involved in the first and rate-limiting step of steroid hormone biosynthesis. By targeting CYP11A1, ACE-232 aims to suppress the production of androgens and other steroid hormones, offering a novel therapeutic mechanism for the treatment of androgen-dependent (including enzalutamide or abiraterone-resistant) prostate cancer. About Acerand Therapeutics Acerand Therapeutics is a biotech company dedicated to discovering and developing novel small-molecule therapies for oncology and metabolic diseases. With research and development hubs in Shanghai, China, and Indianapolis, USA, ACE-232 leverages its proprietary innovation platform and operational efficiency to deliver a highly differentiated pipeline of drug candidates from discovery to clinical trials. View source version on Contacts Acerand Therapeuticsinfo@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store